| Funding Opportunity ID: |
293982 |
| Opportunity Number: |
W81XWH-17-GWIRP-CCA |
| Opportunity Title: |
DoD Gulf War Illness, Clinical Consortium Award |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement
Grant |
| Category of Funding Activity: |
Science and Technology and other Research and Development |
| Category Explanation: |
|
| CFDA Number(s): |
12.420 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
|
| Agency Code: |
DOD-AMRAA |
| Agency Name: |
Department of Defense
Dept. of the Army — USAMRAA |
| Posted Date: |
May 19, 2017 |
| Close Date: |
Sep 21, 2017 |
| Last Updated Date: |
May 19, 2017 |
| Award Ceiling: |
|
| Award Floor: |
|
| Estimated Total Program Funding: |
$8,000,000 |
| Expected Number of Awards: |
1 |
| Description: |
The GWIRP Clinical Consortium Award mechanism is being offered for the first time in FY17. The FY17 GWIRP Clinical Consortium Award is intended to support a major goal-/product-driven Consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic GWI research into clinical therapies and ultimately decrease the impact of the illness. The objectives of the Consortium shall be to conceive, design, develop, and conduct collaborative Phase I and/or II clinical trials of promising therapeutic agents for the management or treatment of GWI. |
| Version: |
Synopsis 1 |
